G. Demonceau

Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.

R. Walovitch, J. Léveillé, G. Demonceau, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantom

S. Walrand, F. Jamar, S. Pauwels, 2011, EJNMMI research.

Healthy Human Subjects

G. Demonceau, 2006 .

99Tcm-HMPAO‐labelled leucocytes for bone marrow scintigraphy and evaluation of skeletal lesions. Comparison with 99Tcm-HSA colloid results

P. Bourgeois, G. Demonceau, M. Stegen, 1991, Nuclear medicine communications.

Ifosfamide (with mesna), vincristine and cis-platinum for carcinoma of the head and neck.

E. Salamon, C. Focan, G. Demonceau, 1983, Cancer treatment reviews.

Randomised trial comparing sequential methotrexate (or 5-FU), vinblastine and ifosfamide to vincristine, adriamycin and ifosfamide in advanced lung cancer.

C. Focan, G. Demonceau, J. Claessens, 1983, Cancer treatment reviews.

Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans.

G Demonceau, R Taillefer, M De Roo, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Muscle imaging in myositis: MRI, US, and PET.

J. Albayda, P. Carlier, G. Demonceau, 2022, Best practice & research. Clinical rheumatology.